Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Healthcare Industry News Laplace Interventional advances life-saving heart valve technology with $22m funding round Laplace Interventional, a Minnesota-based medical device company pioneering transcatheter tricuspid valve replacement technology, has secured $22 million in… byPallavi MadhirajuMarch 17, 2025